Ocugen to Present at the 2024 Cell & Gene Meeting on the Mesa

Core Insights - Ocugen, Inc. is set to present at the 2024 Cell & Gene Meeting on the Mesa, highlighting its focus on gene and cell therapies, as well as vaccines [1][2] - Dr. Shankar Musunuri will discuss Ocugen's modifier gene therapy platform and ongoing clinical trials for retinal diseases, including OCU400, OCU410, and OCU410ST [2][4] - The company aims for BLA and MAA approval for OCU400 by 2026, with the Phase 3 trial currently in progress [2] Company Overview - Ocugen, Inc. is a biotechnology firm dedicated to developing innovative gene and cell therapies and vaccines to improve global health [4] - The company emphasizes its commitment to addressing unmet medical needs in retinal diseases and infectious diseases [4] Event Details - The presentation by Dr. Musunuri is scheduled for October 7, 2024, at 1:30 p.m. MST at the Arizona Biltmore [3] - Virtual attendance options are available for the presentation and other conference sessions [3]